What is Teladoc Inc (TDOC) stock price today?

Teladoc Inc (TDOC) currently trades at $6.06 per share. The stock has a market capitalization of $1.08B and a P/E ratio of —x.

Is TDOC stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Teladoc Inc has a Smart Value Score of 40/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is 4/9 and Altman Z-Score is -5.26.

What is Teladoc Inc's revenue and earnings?

Teladoc Inc has trailing twelve-month (TTM) revenue of $2.53B with profit margins of -7.92%. Earnings per share (EPS) is $-34.20.

Is Teladoc Inc financially healthy?

Teladoc Inc's Piotroski F-Score is 4/9 (moderate financial health). The Altman Z-Score of -5.26 places it in the distress.

TDOC

Teladoc Inc

NYSE: TDOC · HEALTHCARE · HEALTH INFORMATION SERVICES

$6.06

+1.85% today

Updated 2026-04-30

Market cap

$1.08B

P/E ratio

—

P/S ratio

0.43x

EPS (TTM)

$-34.20

Dividend yield

—

52W range

$4 – $10

Volume

5.4M

Market cap

$1.08B

P/E ratio

—

P/S ratio

0.43x

EPS (TTM)

$-34.20

Dividend yield

—

52W range

$4 – $10

Volume

5.4M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

4.0

Growth

5.3

Quality

C+

2.0

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

-5.3

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$7.09

+17.00%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy6 Buy19 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $85.12M — positive

Risks

- Altman Z -5.26 — distress zone

- Thin margins at -7.92%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$2.41B	$2.60B	$2.57B	$2.53B	$2.53B
Net income	$-13.66B	$-220.37M	$-1.00B	$-200.32M	$-25.14M
EPS	—	—	—	—	$-34.20
Free cash flow	$172.81M	$193.67M	$282.89M	$285.46M	$85.12M
Profit margin	-567.53%	-8.47%	-38.97%	-7.92%	-7.92%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TDOC	$1.08B	40	4.0	2.0	5.0	5.3	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Teladoc Inc trades at $6.06. Our Smart Value Score of 40/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -5.26, it sits in the distress. TTM revenue stands at $2.53B. with profit margins at -7.92%.

Frequently asked questions

What is Teladoc Inc's stock price?

Teladoc Inc (TDOC) trades at $6.06.

Is Teladoc Inc overvalued?

Smart Value Score 40/100 (Grade D, Sell).

What is the price target of Teladoc Inc (TDOC)?

The analyst target price is $7.09, representing +17.0% upside from the current price of $6.06.

What is Teladoc Inc's revenue?

TTM revenue is $2.53B.

Piotroski F-Score?

4/9 — moderate financial health.

Altman Z-Score?

-5.26 — distress.

Company info

SectorHEALTHCARE

IndustryHEALTH INFORMATION SERVICES

CountryUSA

ExchangeNYSE

CurrencyUSD

Quick metrics

P/S ratio0.43x

ROE-13.90%

Beta2.08

50D MA$5.33

200D MA$6.90

Shares out0.18B

Float0.18B

Short ratio—

Avg volume5.4M

Performance

1 week+14.12%

1 month+7.38%

3 months-7.32%

YTD-16.86%

1 year—

3 years—

5 years—

Compare

TDOC vs LLY →TDOC vs JNJ →TDOC vs ABBV →Stock screener →